oxymorphone hydrochloride
Generic: oxymorphone hydrochloride
Labeler: amneal pharmaceuticals of new york llcDrug Facts
Product Profile
Brand Name
oxymorphone hydrochloride
Generic Name
oxymorphone hydrochloride
Labeler
amneal pharmaceuticals of new york llc
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Routes
Active Ingredients
oxymorphone hydrochloride 7.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0115-1315
Product ID
0115-1315_a8dc6624-df1e-4e5a-b445-9541658e3430
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA079087
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2013-01-02
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01151315
Hyphenated Format
0115-1315
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
oxymorphone hydrochloride (source: ndc)
Generic Name
oxymorphone hydrochloride (source: ndc)
Application Number
ANDA079087 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 7.5 mg/1
Packaging
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-01)
- 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-03)
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-08)
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-13)
Packages (4)
0115-1315-01
100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-01)
0115-1315-03
1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-03)
0115-1315-08
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-08)
0115-1315-13
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-13)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a8dc6624-df1e-4e5a-b445-9541658e3430", "openfda": {"unii": ["5Y2EI94NBC"], "rxcui": ["977874", "977894", "977902", "977909", "977915", "977923", "977929"], "spl_set_id": ["557e9610-62d7-42bf-90c1-44215bd8c1f8"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-01)", "package_ndc": "0115-1315-01", "marketing_start_date": "20130102"}, {"sample": false, "description": "1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-03)", "package_ndc": "0115-1315-03", "marketing_start_date": "20130102"}, {"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-08)", "package_ndc": "0115-1315-08", "marketing_start_date": "20130102"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0115-1315-13)", "package_ndc": "0115-1315-13", "marketing_start_date": "20130102"}], "brand_name": "Oxymorphone hydrochloride", "product_id": "0115-1315_a8dc6624-df1e-4e5a-b445-9541658e3430", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Full Opioid Agonists [MoA]", "Opioid Agonist [EPC]"], "product_ndc": "0115-1315", "dea_schedule": "CII", "generic_name": "Oxymorphone hydrochloride", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxymorphone hydrochloride", "active_ingredients": [{"name": "OXYMORPHONE HYDROCHLORIDE", "strength": "7.5 mg/1"}], "application_number": "ANDA079087", "marketing_category": "ANDA", "marketing_start_date": "20130102", "listing_expiration_date": "20261231"}